From: SNP-based pathway enrichment analysis for genome-wide association studies
PATHWAYS | Â | European Ancestry (EA) | African Ancestry (AA) | ||||
---|---|---|---|---|---|---|---|
 |  | Nom P | GENE SIZE | SNP SIZE | Nom P | GENE SIZE | SNP SIZE |
HSA04720 | Long-term potentiation | 0.001 | 67 | 66 | <0.001 | 69 | 135 |
HSA04270 | Vascular smooth muscle contraction | <0.001 | 107 | 105 | <0.001 | 113 | 215 |
HSA05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | <0.001 | 72 | 135 | <0.001 | 74 | 144 |
HSA04020 | Calcium signaling pathway | <0.001 | 168 | 165 | <0.001 | 174 | 337 |
HSA04972 | Pancreatic secretion | 0.008 | 93 | 91 | <0.001 | 94 | 184 |
HSA04360 | Axon guidance | <0.001 | 122 | 120 | <0.001 | 126 | 245 |
HSA04080 | Neuroactive ligand-receptor interaction | <0.001 | 256 | 248 | <0.001 | 266 | 509 |
HSA04510 | Focal adhesion | <0.001 | 186 | 186 | <0.001 | 191 | 378 |
HSA04730 | Long-term depression | <0.001 | 68 | 129 | 0.001 | 68 | 134 |
HSA00330 | Arginine and proline metabolism | 0.001 | 47 | 47 | 0.002 | 52 | 102 |
HSA04970 | Salivary secretion | 0.003 | 80 | 151 | 0.002 | 86 | 166 |
HSA05146 | Amoebiasis | 0.009 | 100 | 99 | 0.003 | 103 | 199 |
HSA05414 | Dilated cardiomyopathy | <0.001 | 88 | 86 | 0.005 | 90 | 173 |
HSA04070 | Phosphatidylinositol signaling system | 0.002 | 75 | 74 | 0.006 | 77 | 150 |
HSA04512 | ECM-receptor interaction | 0.001 | 81 | 81 | 0.007 | 82 | 161 |
HSA04260 | Cardiac muscle contraction | 0.009 | 63 | 61 | 0.009 | 67 | 128 |
HSA04540 | Gap junction | 0.003 | 80 | 80 | 0.009 | 85 | 165 |